Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$283K Sell
3,160
-135
-4% -$13K ﹤0.01% 1793
2025
Q4
$306K Buy
3,295
+399
+14% +$43.5K ﹤0.01% 1729
2025
Q3
$361K Buy
2,896
+57
+2% +$7.25K ﹤0.01% 1614
2025
Q2
$374K Buy
2,839
+240
+9% +$27.2K ﹤0.01% 1588
2025
Q1
$272K Sell
2,599
-6,712
-72% -$703K ﹤0.01% 1673
2024
Q4
$1.01M Buy
9,311
+651
+8% +$72.7K 0.01% 978
2024
Q3
$925K Buy
8,660
+1,450
+20% +$147K 0.01% 1007
2024
Q2
$713K Buy
+7,210
New +$726K 0.01% 1116

Other funds holding ITRI

Atria Investments's ITRI Position: Q1 2026 in Review

Atria Investments reduced its Itron (ITRI) stake by 4.1% in Q1 2026, selling an estimated $13K and leaving 3,160 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #1793.

Atria Investments first reported a position in ITRI in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.01M in Q4 2024. 431 funds tracked by Wall St. Rank hold ITRI as of Q1 2026.

  • Atria Investments held 3,160 shares of Itron worth $283K as of Q1 2026.
  • Atria Investments sold 135 Itron shares in Q1 2026, an estimated $13K.
  • Itron made up ﹤0.01% of Atria Investments's portfolio in Q1 2026, its #1793 holding.
  • Atria Investments first reported a position in Itron in Q2 2024 and has held it in 8 quarters since.
  • Atria Investments's Itron position peaked at $1.01M in Q4 2024.
  • 431 funds tracked by Wall St. Rank held Itron as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.